Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | MAT2A | P31153 | 15/20 | 0.46 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.44 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.44 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25643830 | 0.92 | MAT2A (0.40) | L3MBTL1KDM4EATMMAT2AMAPK8 | |
| SCHEMBL25643801 | 0.91 | L3MBTL1 (0.47) | L3MBTL1KDM4EATMMAT2AMAPK8 | |
| SCHEMBL25643826 | 0.91 | MAT2A (0.42) | L3MBTL1KDM4EATMMAT2AMAPK8 | |
| SCHEMBL12447547 | 0.86 | L3MBTL1 (0.63) | L3MBTL1KDM4EATMMAPK8MAPK9 | |
| SCHEMBL21671297 | 0.86 | L3MBTL1 (0.63) | L3MBTL1KDM4EATMMAPK8MAPK9 | |
| SCHEMBL12447557 | 0.86 | L3MBTL1 (0.63) | L3MBTL1KDM4EATMMAPK8MAPK9 | |
| SCHEMBL25643807 | 0.86 | KCNA3 (0.41) | MAT2AMAPK8MAPK9PRMT5CYP1A2 | |
| SCHEMBL25643804 | 0.85 | CYP2A6 (0.39) | MAT2AMAPK8MAPK9PRMT5MEN1 | |
| SCHEMBL26200946 | 0.85 | L3MBTL1 (0.55) | L3MBTL1KDM4EATMMAT2AMAPK8 | |
| SCHEMBL26049225 | 0.85 | L3MBTL1 (0.55) | L3MBTL1KDM4EATMMAT2AMAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230200232-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT COMPRISING SAME, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230200232-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT COMPRISING SAME, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200232-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT COMPRISING SAME, AND ELECTRONIC APPARATUS | EXOSC10, NUDC, NSFL1C | L3MBTL1 2123/4885KDM4E 2341/4885ATM 1669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.